This Paper With 6 Page And PDF Format Ready To Download
Buy and Download
با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 6 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:
Reza Saeedi - Department of pediatrics, School of Medicine, Mashhad university of medical sciences, Mashhad, IranAbdolkarim Hamedi - Department of pediatrics, School of Medicine, Mashhad university of medical sciences, Mashhad, IranAli Javadi - Department of pediatrics, School of Medicine, Mashhad university of medical sciences, Mashhad, IranMahbobeh Gholami Robatsangi - Department of Nursing, faculty member of neyshabur university of medical sciences, Neyshabur, Iran
Background: Using of natural and synthetic surfactant is a rescue treatment for respiratory distress syndrome. In Iran, Survanta and Curosurf are the most frequent used natural surfactant preparations. We compared the clinical response and safety of two surfactants poractant alpha (Curosurf) and beractant (Survanta) for treatment of respiratory distress syndrome (RDS) in preterm infants. Method:This study was a clinical trial study that performed during a 2-year period in Ghaem Center s neonatal care unit.Sample size was calculated with 95% confidence and power 80. 104 premature infants were treated with surfactant, 74 in survanta group and 30 in Curosurf group,. The differences between the two groups were assessed by ANOVA or the calculation of relative risks. Results: There were no statistically significant differences between infants treated with S and C in mean gestational age (30.58 vs. 29.00 weeks) and birth weight (1388 vs.1330 g). Also there was no significant difference between groups, incidence at 28th day of Bronchopulmunary dysplasia (%40.5 vs. %40), Intra ventricular hemorrhage III/IV (%13/5 vs. % 13/3), pneumothorax (%20 vs. % 20), Patent ductus arteriosis (%28/3 vs. % 20), and death (%28 vs. % 26/6). Conclusion:This study concluded that Survanta and Curosurf are similar in treatment of neonatal respiratory distress syndrome.
This Paper COI Code is JR_IRJN-4-3_002. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:
How to Cite to This Paper:
If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Saeedi, Reza and Hamedi, Abdolkarim and Javadi, Ali and Gholami Robatsangi, Mahbobeh,1392,Comparison of side effect of survanta and curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem Hospital On 2006-2008,https://civilica.com/doc/935374
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Slattery MM, Morrison JJ. Preterm delivery.Lancet .2002; 360: 1489–1497. ...